Section Review Central & Peripheral Nervous Systems: P₂-Purinoceptors: Advances and therapeutic opportunities

References

• BURNSTOCK G: P2-purinoceptors: historical perspective and classification. In: P2-Purinoceptors: Localization, Function and Transduction Mechanisms. Ciba Foundation Symposium 198. G Bumstock (Ed.). John Wiley, Chichester, UK (1996). In press.
   Google Scholar
• This overview will appear early in 1996 and is the authoritative source on the history of the purinoceptor field.
   Google Scholar
• HARDEN TK, BOYER JL, NICHOLAS RA: P2-purinergic receptors: subtype-associated signaling responses andstructure. Ann. Rev. Pharmacol. Toxicol. (1995) 35:541-579. A thorough overview of the P2 receptor area from a molecular and pharmacological perspective.
   Google Scholar
• DI VIGILIO F: The purinergic P2z receptor: an intriguing role in immunity, inflammation and cell death. Immu-nol. Today (1995). In press.
   Google Scholar
• An important overview of the potentially pivotal role played by ATP in apoptosis.
   Google Scholar
• NEARY JT, NORENBERG MD: Signaling by extracellular ATP: physiological and pathological considerations in neuronal-astrocytic interactions. Frog. Brain. Res. (1992) 94:145–151.
   PubMed Web of Science ®Google Scholar
• NEARY JT, RATHBONE MP, CATTABENI F, ABBRACCHIO MP, BURNSTOCK G: Trophic actions of extracelhilarnucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. (1995). In press.
   Google Scholar
• An overview of the role of ATP, and related purines and nucleotides as trophic factors in nervous tissue.
   Google Scholar
• DRURY AN, SZENT-GYORGI A: The physiological action of adenine compounds with especial reference to their action on mammalian heart. J. Physiol. (Lond.) (1929) 68:214–237.
   Google Scholar
• The seminal paper in purinergic receptor research.
   Google Scholar
• HOLTON RA, HOLTON P: The capillary dilator sub-stances in dry powders of spinal roots: a possible role for ATP in chemical transmission from nerve endings. J. Physiol. (Lond.) (1954) 126:124–140.
   Google Scholar
• BURNSTOCK G: Purinergic nerves. Pharmacol. Rev. (1972)24:509–581.
   PubMed Web of Science ®Google Scholar
• BURNSTOCK G: A basis for distinguishing two types of purinergic receptor. In: Cell Membrane Receptors for Drugs and Hormones. Bolis L, Straub RW (Eds.). Raven Press, New York (1978):107–118.
   Google Scholar
• The paper in which the existence of Pi and P2 receptors was initially proposed.
   Google Scholar
• CUSACK NJ, HOURANI SM: Subtypes of P2-purinoceptors: studies using analogues of ATP. Ann. IVY Acad. Sci. (1990) 603:172–181.
   PubMed Web of Science ®Google Scholar
• BOUCHER RC, KNOWLES MR, OLIVIER KN, BENNETT W,MASON SJ, STUTTS MJ: Mechanisms and therapeutic actions of uridine triphosphate in the lung. In: Adeno-sine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology. Bellardinelli L, Pelleg A (Eds.). Klu-wer, Boston (1995):525–532.
   Google Scholar
• MIDDLEMISS PJ, GYSBERS JW, RATHBONE MP: Extracel-lular guanosine and guanosine 5' triphosphate increase NGF synthesis and release from cultured mouse neopal-Hal astrocytes. Brain Res. (1995). In press.
   Google Scholar
• WILLIAMS M: Purinoceptors in central nervous system function. Targets for therapeutic intervention. In: Psychopharrnacology: The Fourth Generation of Progress. Bloom FE, Kupfer DJ (Eds.). Raven Press, New York (1995):643–655.
   Google Scholar
• An overview on the role of purines in CNS function.
   Google Scholar
• EVANS RJ, DERKACH V, SURPRENANT A: ATP mediates fast synaptic transmission in mammalian neurons. Nature (1992) 357:505–507.
   PubMedGoogle Scholar
• EDWARDS FA, GIBB AJ, COLQUHOUN D: A'FP receptor-mediated synaptic currents in the central nervous sys-tem. Nature (1992) 359:144–147.
   PubMed Web of Science ®Google Scholar
• KENNEDY C, LEFF P: How should P2x-purinoceptors be classified pharmacologically? Trends Pharmacol. Sci.(1995) 16:168–174.
   Google Scholar
• An important commentary on the role of ectonucleotidases in defining rank order potency of ATP analogues in characterising P2-purinoceptors. A cautionary reminder as to why agonists are not always (? never) the best ligands to define receptor pharmacology.
   Google Scholar
• EHRLICH YH, SNYDER RM, KORNECKI E, GARFIELD MG, LENOX RH: Modulation of neuronal signal transduction systems by extracellular ATP. J. Neurochem. (1988) 50:295–301.
   PubMed Web of Science ®Google Scholar
• ABBRACCHIO M, CERUTI S, BURNSTOCK G, CATTABENIF: Purinoceptors on g,lial cells of the central nervous system: functional and pathological implications. In: Adenosine and Adenine Nucleotides: Front Molecular Biology to Integrative Physiology. Bellardinelli L, Pelleg A (Eds.). Kluwer, Boston (1995):271–280.
   Google Scholar
• BURNSTOCK G, KENNEDY C: Is there a basis for distin- guishing two types of P2-purinoceptor? Gen. Pharmacol.(1985) 16:433–440.
   Google Scholar
• A seminal paper in the history of P2 receptor nomenclature.
   Google Scholar
• GORDON J: Extracellular ATP: effects, sources and fate. Biochem J. (1986) 233:309–319.
   PubMed Web of Science ®Google Scholar
• Yet another seminal paper in the history of P2 receptor nomenclature. The use of T' and 'Z' to define receptors continues to perplex those used to A following B and so on.
   Google Scholar
• DUBYAK GR, EL-MOATASSIM C: Signal transduction via P2-purinergic receptor for extracellular ATP and other nucleotides. Am. J. Physiol. (1993) 265:577–606.
   PubMed Web of Science ®Google Scholar
• An important overview that provided the basis to delineate the two main P2 receptor families on the basis of signal transduction mecha-nisms and, eventually, structure.
   Google Scholar
• ABBRACCHIO MP, BURNSTOCK G: Purinoceptors: are there superfamilies of P2x and P2y purinoceptors? Phar-macol. Ther. (1994) 64:445–475.
   Google Scholar
• Yet another seminal paper from the Bumstock camp providing the stimulus to redefine the P2 receptor area. While this paper provided some intriguing pharmacological data as a framework to define the eleven receptors outlined, these have been overtaken by incredibly energetic efforts on the cloning front.
   Google Scholar
• SURPRENANT A, BUELL G, NORTH RA: P2x receptors bring new structure to ligand-gated ion channels. TrendsNeurosci. (1995) 18:224–229.
   Web of Science ®Google Scholar
• A very nice synthesis of electrophysiological, pharmacological and molecular biological data to support the existence of the P2x purinoceptor superfamily.
   Google Scholar
• BOARDER MR, WEISMAN GA, TURNER JT, WILKINSON GF: G-protein-coupled P2-purinoceptors: from molecularbiology to functional response. Trends Pharmacol. Sci. (1995) 16:133–139.
   PubMed Web of Science ®Google Scholar
• A very nice synthesis of electrophysiological, pharmacological and molecular biological data to support the existence of the P2y purinoceptor superfamily.
   Google Scholar
• LAZAROWSKI ER, HARDIN TK: Identification of a urkiine nucleotide-sensitive G-protein-linked receptor that ac-tivates phospholipase C. J. Biol. Chem. (1994) 269:11830–11836.
   PubMed Web of Science ®Google Scholar
• The first evidence that there may be P2u receptors that respond to UTP only.
   Google Scholar
• FREDHOLM B13, ABBRACCHIO MP, BURNSTOCK G, DALY JW, HARDIN TK, JACOBSON KA, LEFF P, WILLIAMS M: Nomenclature and classification of purinoceptors: a report from the IUPHAR Subcommittee. Pharmacol. Rev. (1994) 46:143–156.
   PubMed Web of Science ®Google Scholar
• JACOBSON KA, FISCHER B, MALLIARD M, BOYER JL, HOYLE CITV, HARDIN TK, BURNSTOCK G: Novel ATP agonists reveal receptor heterogeneity within P2x and P2y subtypes. In: Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology. Bellardinelli L, Pelleg A (Eds.). Kluwer, Boston (1995):149–166.
   Google Scholar
• WEBB TE, SIMON J, KRISHEK BI, BATESON AN, SMART TG, KING BJ, BURNSTOCK G, BARNARD EA: Cloning and functional expression of a cDNA encoding a brain P2y purinoceptor. FEBS Lett. (1993) 324:219–225.
   PubMed Web of Science ®Google Scholar
• LUSTIG KD, SHIAU AK, BRAKE AJ, JULIUS D: Expression cloning of an ATE! receptor from mouse neuroblastorna cells. Proc. Natl. Acad. Sci. USA (1993) 90:5113–5117.
   PubMed Web of Science ®Google Scholar
• VALERA S, HUSSY N, EVANS RJ, ADAMI N, NORTH RA, SURPRENANT A, BUELL G: A new class of ligand-gated Ion channel defined by P2x receptor for ATP. Nature (1994) 371:516–519
   PubMed Web of Science ®Google Scholar
• BRAKE AJ, WAGENBACH MJ, JULIUS D: New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature (1994) 371:519–523.
   PubMed Web of Science ®Google Scholar
• CHEN CC, AKOPIAN AN, SIVILOTH L, COLQUHOUN D, BURNSTOCK G, WOOD JN: A P2x receptor expressed bya subset of sensory neurons. Nature (1995). In press. The cloning and expression of a new ATP receptor that is potentially involved in pain processing,
   Google Scholar
• EVANS RJ, LEWIS C, BUELL G, VALERA S, NORTH RA, SUPRENANT A: Pharmacological characterization of het-erologously expressed ATP-gated cation channels (P2x receptors). Mol. Pharmacol. (1995) 48:178–183.
   PubMed Web of Science ®Google Scholar
• SIMON J, WEBB TE, BARNARD EA: Characterization of a P2y-purinoceptor in the brain. Pharmacol. Toxicol. (1995) 76:302–307.
   PubMedGoogle Scholar
• WILLIAMS M, JACOBSON KA: Radioligand binding assays. In: Adenosine and Adenosine Receptors. Williams M (Ed.). Humana, Clifton, NJ (1990):17–55.
   Google Scholar
• BOYNAEMS J-M, COMMUNI D, MO1'iF. S, PARMENTIER M, PIROTTON S: Function of purinoceptors in endothelial cells. In: P2 Purinoceptors: Localization, Function and Transduction Mechanisms. Ciba Foundation Symposium 198. Burnstock G (Ed.). John Wiley, Chichester, UK (1996). In press.
   Google Scholar
• BARNARD EA, WEBB TE, SIMON J, KING BF, BURNSTOCK G: Cloning and functional expression of neuronal P2y-purinoceptors. In: P2-Purinoceptors: Localization, Func-tion and Transduction Mechanisms. Ciba Foundation Symposium 198. Burnstock G (Ed.). John Wiley, Chichester, UK (1996). In press.
   Google Scholar
• CUSACK NJ: P2 receptor: subclassification and structure- activity relationships. Drug Dev. Res. (1993) 28:244-252. A historical account of the considerable efforts of Noel Cusack in being, for many years, the only source of P2 receptor ligands.
   Google Scholar
• VAN RHEE AM, VAN DER HEIJDEN MPA, BEUKERS M, IJZERMAN AP, SOUDIJN W, NICKEL P: Novel competitive antagonists for P2-purinoceptors. Fur. J. Pharmacol. (1994) 268:1–7
   Google Scholar
• KING BF, WANG S, ZIGANSHIN AU, ZIGANSHINA LE, SPEDDING M, BURNSTOCK G: 2'-2'-Pyridylisatogen po-tentiates ATP agonism at a recombinant P2y2 purino-ceptor. Br.]. Pharmacol (1994) 113:60P.
   Google Scholar
• COOPER CL, MORRIS AJ, HARDEN TK: Guanine nucleo-tide-sensitive interaction of a radiolabeled agonist with a phospholipase C-linked P2-purinergic receptor./ Biol. Chem. (1989) 264:6202–6206.
   PubMed Web of Science ®Google Scholar
• BOX, BURNSTOCK G: High and low affinity binding sites for [3111-a, I3-methylene ATP in rat urinary bladder mem-branes. Br. J. Pharrnacol. (1990) 101:291–296.
   PubMed Web of Science ®Google Scholar
• BO X, SIMON J, BURNSTOCK G, BARNARD EA: Solubiliza-tion and molecular size determination of the Pax-puri-noceptor from rat vas deferens. J. Biol. Chem. (1992) 267:17581–17587.
   PubMedGoogle Scholar
• MICHEL AD, HUMPHREY PPA: Distribution and charac-terisation of [311]-cc,P-methylene ATP binding sites in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. (1993) 348:608–617.
   Google Scholar
• BOYER JL, COOPER CL, HARDEN TK: Photoaffinity label-ing of the Pzy-purinergic receptor by [3211-3'-0-(4-ben-zoyObenzoyl adenosine-5-triphosphate. J. Biol. Chem. (1990) 265:13515–13520.
   PubMedGoogle Scholar
• BALCAR VJ, LI Y, KILLINGER S, BENNETT MR: Autoradiog-raphy of Pzx ATP receptors in the rat brain. Br. J. Pharmacol. (1995) 115:302–306.
   PubMedGoogle Scholar
• RAPAPORT E: Anticancer activities of adenine nucleotides in tumor bearing hosts. Drug Dev. Res. (1993)28:428–431.
   Web of Science ®Google Scholar
• An account of the use of ATP in treating tumour growth potentially focusing on the apoptotic properties of P2z receptor activation.
   Google Scholar
• FUKUNAGA AF, MIYAMOTO TA, K1KUTA Y, KANEKO Y, IPICHINOHE T: Role of adenosine and adenosine triphos-phate as anesthetic adjuvants. In: Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiol-ogy. Bellardinelli L, Pelleg A (Eds.). Kluwer, Boston (1995):511–523.
   Google Scholar
• A detailed account of clinical studies involving over 1000 patients using ATP to reduce anaesthesia usage and improve their safety profile
   Google Scholar
• SEGERDAHL M, EKBLOM A, SANDELIN K, WICKMAN M, SOLLEVI A: Perioperative adenosine infusion reduces the requirement for isoflurane and postoperative anal-gesics. Anesth. Analg. (1995) 80:1145–1149.
   PubMed Web of Science ®Google Scholar
• SAWYNOK J, SWEENEY MI: The role of purines in no-ciception. Neuroscience (1989) 32:557–569.
   PubMed Web of Science ®Google Scholar
• HUMPHRIES RG, ROBERTSON MI, LEFF P: A novel series of Pzr-purinoceptor antagonists: definition of the roleof ADP in arterial thrombosis. Trends Pharmacol. Sci. (1995) 16:179–181.
   PubMed Web of Science ®Google Scholar
• An overview of the novel Pzr receptor antagonist, ARL 67085. The research program that led to this very interesting molecule was based on the identification of an opportunity to develop an improved antithrombotic agent using available data on structure-activity rela-tionships for stable purine nucleotide ligands and a body of biologi-cal knowledge related to ADP, ATP and platelet function that had been available for over two decades. These comments by no means diminish the significant achievements of the Astra Charnwood group, but this article does point out that the recognition and application of existing knowledge to a specific therapeutic target can be as crucial to a successful outcome for a drug discovery project as enabling technology, i.e., intellect still counts!
   Google Scholar
• BURNSTOCK G: Purinoceptor Update Newsletter 2. (Septemesber, 1995).
   Google Scholar
• A newsletter produced by Geoff Bumstock and colleagues that provides an on-going 'clearing house' for new information regarding receptor cloning and pharmacological characterisation. This informal newsletter is intended to aid the efforts of the IUPHAR Committee on Receptor Nomenclature by providing a framework to designate P2 receptors in a sequential manner and avoid duplication of designators. The newsletter is available from Professor Bumstock who can be contacted via fax on +44 (0) 171 380 7349 in London, UK. (Additional information about purinoceptors is available at the World Wide Web at http://mgddkl.niddk.nih.gov:8000/).
   Google Scholar